Approval of Osimertinib and Necitumumab Increases Lung Cancer Treatment Options

Main|Search|PHGKB



From National Institutes of Health Web Sites

---

• Approval of Osimertinib and Necitumumab Increases Lung Cancer Treatment Options  
• Frequently Asked Questions about the Sudden Death in the Young Case Registry  
  CDC and NHLBI collaboration